L. Nagarapu et al. / Tetrahedron 68 (2012) 5829e5832
5831
chromatography (TLC) employing 0.25 mm silica gel plates (60F-
254, E-Merck). Column chromatography was performed using Acme
silica gel (60e120 mesh). Visualization of the spots onTLC plates was
achieved either by exposure to UV light, iodine vapor and by dipping
the plates in phosphomolybdic acideceric (IV) sulfateesulfuric acid
solution (PMA solution) and heating the plates at 120 ꢀC.
13C NMR (300 MHz, CDCl3):
d
14.2, 25.2, 27.6, 60.6, 61.8, 75.9, 78.2,
109.5, 123.0, 142.0, 165.8. MS (ESI): m/z 253 (MþNa)þ. HRMS: calcd
for C8H14O5Na: 253.10464. Found 253.10406.
4.1.4. Ethyl 3-((4R,5S)-5-(hydroxymethyl)-2,2-dimethyl-1,3-
dioxolan-4-yl)propanoate (8). To a stirred solution of conjugated
alkene 7 (8.2 g, 35.6 mmol) in MeOH (100 mL), NiCl4$6H2O (1.7 g,
7.13 mmol) was added at 0 ꢀC. The resulting mixture was stirred at
4.1.1. (3aR,6R,6aR)-6-(Hydroxymethyl)-2,2-dimethyltetrahydrofuro
[3,4-d][1,3]dioxol-4-ol (5). To a stirred solution of
D-ribose (4)
0
ꢀC for 10 min and NaBH4 (2.7 g, 71.3 mmol) was added in small
(10.0 g, 66.6 mmol) in acetone (100 mL), concd H2SO4 (0.3 mL) was
added drop wise at room temperature. And the resulting reaction
mixture was stirred at room temperature for 2 h, until TLC showed
complete conversion of the starting material. The reaction mixture
was neutralized by addition of solid NaHCO3 and filtered to remove
inorganic solid. The filtrate was concentrated under reduced pres-
sure to give colorless syrup. The residue was purified by silica gel
column chromatography using hexane and ethyl acetate (30%) as
the eluent to afford 5 as colorless syrup (11.7 g, 92.4%); Rf 0.4 (50%
portions. The reaction mixture was stirred for another 3 h and
quenched with water. The whole reaction mixture was concen-
trated to get the residue, which was extracted with EtOAc. The
organic extract was washed with brine and dried over anhydrous
Na2SO4, and evaporated. The crude reaction mixture was purified
by silica gel column chromatography using EtOAc/hexane (25%) as
an eluent to provide the corresponding saturated ester compound 8
(7.8 g, 94.9%) as a clear oil. Rf 0.5 (50% EtOAc/hexane); ½a D28
þ21.3 (c
ꢂ
2.1, CHCl3); IR (KBr, neat): 1041, 1163, 1250, 1372, 1732, 2934, 2985,
EtOAc/hexane); ½a D28
ꢂ
ꢁ36.7 (c 1.1, acetone); IR (KBr, neat): 869,
3472; 1H NMR (300 MHz, CDCl3):
d
1.26 (3H, t, J¼7.17 Hz, CH3CH2),
1068, 1211, 1376, 1458, 1635, 2940, 2986, 3408; 1H NMR (300 MHz,
1.32 (3H, s, CH3),1.43 (3H, s, CH3),1.77e1.85 (2H, m, CH2), 2.31e2.55
(2H, m, CH2), 3.60e3.63 (2H, m, CH2OH), 4.08e4.17 (4H, m, 2CH,
CDCl3):
d 1.32 (3H, s, CH3), 1.49 (3H, s, CH3), 3.74 (2H, s, CH2OH), 4.41
(1H, s, CHCH2), 4.59 (1H, d, J¼6.04 Hz, CH), 4.84 (1H, d, J¼5.66 Hz,
CH2CH3); 13C NMR (300 MHz, CDCl3):
d 14.1, 24.5, 25.3, 28.0, 31.0,
CH), 5.42 (1H, s, CHOH); 13C NMR (300 MHz, CDCl3):
d
24.5, 26.2,
60.4, 61.4, 75.9, 77.7, 108.2, 173.1; MS (ESI): m/z 255 (MþNa)þ;
63.3, 81.5, 86.5, 87.5, 102.5, 112.0; MS (ESI): m/z 213 (MþNa)þ;
HRMS: calcd for C8H14O5Na: 255.12029. Found 255.12007.
HRMS: calcd for C8H14O5Na: 213.07334. Found 213.07304.
4.1.5. Ethyl
3-((4R,5R)-5-formyl-2,2-dimethyl-1,3-dioxolan-4-yl)
4.1.2. (3aS,6aS)-2,2-Dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-ol
propanoate (9). To a stirred solution of IBX (4.1 g, 15.0 mmol) in dry
DMSO (10 mL), a solution of compound 8 (2.5 g, 10.7 mmol) in THF
(60 mL) was added drop wise at room temperature. The resulting
reaction mixture was stirred for 3 h until TLC showed complete
conversion of the starting material. The reaction mixture was
quenched by addition of cold water (15 mL) and diluted with
diethyl ether (50 mL). Organic layer was separated and washed
with satd NaHCO3 (2ꢃ10 mL), dried (Na2SO4), and concentrated
under reduced pressure to obtain the title compound 9 (2.28 g,
92.3%) as a thick syrup, which was used further without purifica-
tion. Rf 0.8 (50% EtOAc/hexane); IR (KBr, neat): 1074, 1272, 1373,
(6). To a stirred solution of
D-ribose monoacetonide 5 (11.0 g,
57.8 mmol) in dry methanol (70 mL), NaBH4 (3.29 g, 86.8 mmol) was
added in small portions at 0 ꢀC. And the resulting reaction mixture
was stirred at room temperature for 1 h until TLC showed complete
conversion of starting material. Then the solvent was distilled off
t
under reduced pressure, and then BuOH/H2O (90/60 mL), NaIO4
(49.5 g, 231.5 mmol) were added in small portions at room tem-
perature. And the resulting reaction mixture was stirred at room
temperature for 12 h until TLC showed complete conversion of
stirring material. The reaction mixture was diluted with CH2Cl2
(200 mL) and neutralized by the addition of solid NaHCO3 and fil-
tered to remove inorganic solid. The filtrate was extracted into
CH2Cl2 (2ꢃ50 mL), dried (Na2SO4), and concentrated under reduced
pressure to obtain a residue, which was chromatographed [SiO2,
60e120 mesh, hexane/ethyl acetate, 75/25] to obtain the title
1454, 1732, 2931; 1H NMR (500 MHz, CDCl3):
d 1.25 (3H, t,
J¼7.32 Hz, CH3), 1.40 (3H, s, CH3), 1.57 (3H, s, CH3), 1.99e2.13 (2H, m,
CH2), 2.39e2.55 (2H, m, CH2), 4.14 (2H, q, J¼7.32,14.64 Hz, CH2CH3),
4.29e4.33 (1H, m, CH), 4.36e4.41 (1H, m, CH), 9.67 (1H, d,
J¼2.44 Hz, CHO); 13C NMR (300 MHz, CDCl3):
d 14.1, 19.1, 25.2, 27.6,
compound 6 (7.3 g, 78.9%) as an oil. Rf 0.4 (30%EtOAc/hexane); ½a D28
ꢂ
30.9, 60.5, 71.7, 81.7, 110.6, 172.5, 201.8. MS (ESI): m/z 253 (MþNa)þ.
ꢁ76.1 (c 1.3, CHCl3); IR (KBr, neat): 1067,1210,1375,1459,1633, 2925,
HRMS: calcd for C8H14O5Na: 253.10464. Found 253.10493.
3433; 1H NMR (300 MHz, CDCl3):
d 1.29 (3H, s, CH3),1.44 (3H, s, CH3),
3.91e4.06 (2H, m, CH2), 4.51 (1H, d, J¼5.66 Hz, CH), 4.77e4.81 (1H,
4.1.6. Methyl 3-((4R,5S)-5-ethynyl-2,2-dimethyl-1,3-dioxolan-4-yl)
propanoate (10). To a stirred solution of K2CO3 (2.4 g, 17.4 mmol)
and dimethyl-1-diazo-2-oxopropylphosphonate (1.8 g, 9.56 mmol)
in dry MeOH (15 mL), aldehyde 9 (2.0 g, 8.7 mmol) dissolved in dry
MeOH (5 mL) was added drop wise at room temperature. The
resulting mixture was stirred for 4 h until TLC showed complete
conversion of the starting material. The reaction mixture was fil-
tered to remove inorganic solid, and the filtrate was concentrated
under reduced pressure to obtain alkyne compound 10 (1.38 g,
dd, J¼3.39, 5.66 Hz, CH), 5.35 (1H, s, CHOH); 13C NMR (300 MHz,
CDCl3):
d 24.5, 26.0, 71.6, 79.8, 85.0, 101.5, 112.1; MS (EI): m/z 183
(MþNa)þ; HRMS: calcd for C8H14O5Na: 183.04957. Found 183.04913.
4.1.3. Ethyl3-((4R,5S)-5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-
4-yl)acrylate (7). To a solution of compound 6 (7.1 g, 44.3 mmol) in
CH2Cl2 (80 mL), ethoxycarbonylmethylene triphenylphosphonate
(21.6 g, 62.1 mmol), and benzoic acid (0.3 g) were added at room
temperature. The resulting reaction mixture was refluxed at ꢀC for
18 h until TLC showed complete conversion of the starting material.
The reaction mixture was allowed to come to room temperature
and concentrated under reduced pressure to obtain a residue,
which was chromatographed [SiO2, 60e120 mesh, hexane/ethyl
acetate, 80/10] to obtain the title compound 7 (9.0 g, 89.0%) as
75.0%) as pale yellow oil. Rf 0.7 (30% EtOAc/hexane); ½a D28
ꢁ17.1 (c
ꢂ
1.1, CHCl3); IR (KBr, neat): 863, 1064, 1226, 1371, 1738, 2934, 2987,
3272; 1H NMR (300 MHz, CDCl3):
d 1.33 (3H, s, CH3), 1.52 (3H, s,
CH3), 2.01e2.13 (2H, m, CH2), 2.45e2.54 (3H, m, CH2, CH), 3.69 (3H,
s, CH3), 4.10e4.17 (1H, m, CH), 4.77 (1H, dd, J¼2.26, 5.66 Hz, CH); 13
C
NMR (300 MHz, CDCl3): d 25.8, 26.2, 27.6, 30.3, 51.6, 68.7, 76.0, 76.5,
analytically pure low melting solid. Rf 0.5 (30%EtOAc/hexane); ½a D28
ꢂ
79.4, 109.8, 173.4; MS (ESI): m/z 235 (MþNa)þ; HRMS: calcd for
ꢁ139 (c 1.1, CHCl3); IR (KBr, neat): 1049, 1163, 1216, 1372, 1720,
C8H14O5Na: 235.09408. Found 235.09374.
2932, 2985, 3483; 1H NMR (300 MHz, CDCl3):
d 1.30 (3H, t,
J¼7.16 Hz, CH3CH2), 1.38 (3H, s, CH3), 1.51 (3H, s, CH3), 4.11e4.24
(4H, m, 2ꢃ CH2), 4.29e4.36 (1H, m, CH), 4.74e4.81 (1H, m, CH), 6.08
(1H, dd, J¼1.51, 15.48 Hz, CH), 6.86 (1H, dd, J¼5.66, 15.86 Hz, CH);
4.1.7. Methyl-3-((4R,5S)-2,2-dimethyl-5-((E)-pent-3-en-1-ynyl)-1,3-
dioxolan-4-yl)propanoate (11). To a stirred solution of Pd(PPh3)2Cl2
(264 mg, 0.377 mmol) and CuI (229 mg, 1.20 mmol) in piperidine